vimarsana.com

Page 81 - Advanced Cellular Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Issues Alert to Mitigate Risks to a Widely Used Allergy, Nausea Drug

The FDA said promethazine hydrochloride, a generic drug used to manage allergies and motion sickness, should be administered by intramuscular injection. Intravenous injection can cause chemical irritation and tissue damage, an FDA alert states.

Medicaid Spending on Prescriptions Has Risen Despite Lower Utilization

A new KFF report analyzed recent trends in Medicaid outpatient prescription drug utilization and spending. It discovered that although there's been lower utilization of prescription drugs in recent years, Medicaid spending on prescription drugs has increased.

How Can Hospitals Prepare for 2024 s Cyberthreats?

Many hospitals remain underprepared to protect themselves against cybercriminals’ barrage of increasingly sophisticated attacks, but there are a couple concrete steps they can take to build a stronger defense structure like virtual patching and thinking twice about moving to the cloud.

Cytokinetics Heart Drug s Trial Data Look Competitive With BMS Med Camzyos

Cytokinetics drug aficamten met the main goal of a pivotal test in obstructive hypertrophic cardiomyopathy. If approved, the daily pill would compete against a Bristol Myers Squibb drug projected to become a blockbuster seller.

Mark Stamper, Author at MedCity News

Mark Stamper, Author at MedCity News
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.